There are a wide variety of molecular mechanisms that ensure faithful entry, progression, and exit during the cell cycle. These tightly regulated mechanisms include activation and inactivation of cyclin-dependent kinases (CDKs), expression and degradation of cyclins, and expression of inhibitors of CDK-cyclin complexes. Deregulation of cell-cycle control is a hallmark of many human malignancies. Ruijtenberg and van den Heuvel now reveal that, in a cell lineagespecific fashion, a SWI/SNF chromatinremodeling complex genetically interacts with core G1/S cell-cycle regulators and plays an important and redundant role in muscle cell-cycle exit and muscle differentiation in C. elegans (Ruijtenberg and van den Heuvel, 2015) .
To study cell-cycle exit in vivo, the authors developed a conditional knockout and lineage-tracing system in C. elegans. Optimizing several aspects of the established Cre/lox-based technologies for gene knockout and lineage tracing, the authors established a faithful system for inactivating a gene of interest in a particular lineage and following the mutant cells and their progeny. The method involves generating a homozygous genomic mutation of the gene of interest and then integrating a single-copy transgene encoding a floxed wild-type copy of the gene along with the fluorescent protein reporters, mCherry and GFP. The wildtype copy of the gene and mCherry are expressed while GFP is silent. Subsequent expression of CRE recombinase from tissue-specific promoters leads to deletion of the floxed gene in a particular lineage while activating GFP, allowing identification of mutant cells. This elegant technique allowed them to dissect the mechanism of cell-cycle exit in different lineages and furthermore to screen for chromatin regulators of this process during muscle terminal differentiation.
Applying this approach to intestinal and muscle cell lineages, the authors uncovered lineage-specific differences in the requirements for cell-cycle regulators to induce differentiation and quiescence. Loss of the G1/S inhibitors lin-35/Rb and fzr-1/Cdh1 in intestinal cells results in failure of cell-cycle exit and extra cell divisions (hyperplasia), whereas loss of these inhibitors does not alter the cell division and differentiation pattern of postembryonic mesoderm (M) lineage, which gives rise to muscle cells. These findings point to the participation of other cell-cycle exit regulators that remain in place even in the absence of Rb and Cdh1.
To address this question, the authors performed a candidate-based RNAi screen on animals lacking lin-35/Rb and fzr-1/Cdh1. The screen hits included the known CDK inhibitors CKI-1 and Kip1 and two SCF-like E3 ubiquitin ligase subunits. What they further discovered were members of the SWI/SNF chromatin-remodeling complex. The loss of SWI/SNF function in the absence of Rb and Cdh1 abrogated cell-cycle exit in the M lineage, but not in the intestine, revealing unexpected, differential mechanisms at play that control the cell cycle in different cell lineages. This finding raised the interesting question of what function a chromatin remodeler could have in regulating lineage-specific cellcycle arrest during differentiation.
SWI/SNF complexes remodel chromatin structure by moving or ejecting nucleosomes to provide or potentially block access to DNA at target genes (Cairns, 2009 ). This remodeler has gained attention from the cancer community as SWI/SNF subunits are mutated in 19.6% of all human tumors, as reported in 44 studies (Kadoch et al., 2013) . For instance, SNF5 mutations are found in nearly all rhabdoid tumors, BAF180 mutations in 41% of renal cell carcinomas, ARID1A mutations in 50% of ovarian clear cell carcinomas, and BRG1 mutations in 15%-50% of human primary non-smallcell lung cancer samples (Wilson and Roberts, 2011) . However, the molecular mechanisms by which SWI/SNF complexes participate in the regulation of cell proliferation and tumorigenesis are not fully understood.
Multiple studies have hinted at essential roles for chromatin remodeling in cellcycle regulation and differentiation. For instance, a whole-mouse knockout of one SWI/SNF component, Brm, resulted in hyperplasia of select organs and increased cellular proliferation (Reyes et al., 1998) . Recently, the human SWI/ SNF subunit BAF47 has been reported to be required for cell-cycle withdrawal by silencing cyclin D1 during skeletal muscle terminal differentiation (Joliot et al., 2014) . These studies, in composite, suggest a role for chromatin remodeling in promoting cell-cycle exit and differentiation, although the nature and extent of the requirement has varied between studies. Furthermore, the precise interactions of chromatin remodelers and other cell-cycle regulatory pathways remains ambiguous: in some cases, SWI/SNF appears to act in concert with Rb to regulate the cell cycle (Zhang et al., 2000) , while in others it primarily induces a differentiation program (de la Serna et. al., 2001 ).
In the current study, Ruijtenberg and van den Heuvel demonstrate, in whole animals, that the SWI/SNF-remodeling complex regulates expression of both positive and negative regulators of cell cycle during muscle differentiation in the M lineage. Expression of positive cell-cycle regulators cye-1 cyclin E and cdk-4 increased, while expression of negative regulators of cell cycle cki-1 and cdc-14, and muscle-specific genes such as myo-3, decreased in the absence of an intact (likely muscle cell-specific) SWI/SNF complex (Figure 1) . Surprisingly, SWI/SNF provided a layer of regulation on top of Rb-induced cell-cycle arrest in M cells, in contrast to other systems where the effects of chromatin and Rb are largely inter-dependent (Harel-Bellan et al., 1998; Zhang et al., 2000) . These findings integrate the previous reports of SWI/SNF requirements for cell-cycle exit, induction of lineage-specific transcription programs, and interplay with the classical cell-cycle regulators. The combined inactivation of cell-cycle genes and SWI/SNF resulted in tumor-like over-proliferation of M cells, mimicking a cancerous state in this simple model system.
This study represents an important step in understanding in vivo functions of chromatin regulators in cell-cycle control. It also raises many interesting and exciting questions for future studies. SWI/SNF complexes have been shown to undergo changes in subunit composition during development (Lessard et al. 2007) , and presumably these changes impart specific functions to those SWI/SNF complexes with subtle yet important biochemical differences. Therefore, it will be important to know the biochemical composition of this muscle-cell-specific SWI/SNF complex. Additional questions include: how is this complex targeted to intended chromatin locations? How does it specifically activate the expression of negative cell-cycle regulators but repress positive regulators? Is the chromatin-remodeling activity of the complex required? Given the central contribution of Rb, addressing the molecular basis of its redundant function with this SWI/SNF complex should be investigated. Importantly, the identification of SWI/SNF as an independent and important cell-cycle regulator will not only provide mechanistic insights into chromatin remodeling in regulating cell-cycle exit and differentiation, but also open up new avenues in the diagnosis and treatment of cancer. The SWI/SNF complex plays a lineage-specific role in cell-cycle regulation in the mesoblast (M) lineage, but not in intestinal cells, during terminal differentiation. This complex has both positive and negative effects on gene expression, being required for inhibiting positive cell-cycle regulators like CYE-1 and CDK-4 and activating negative regulators such as CKI-1 and CDC-14. In addition, the authors demonstrate that SWI/SNF acts in concert with MyoD and antagonizes Polycomb-mediated transcriptional repression (not shown). These interactions, in composite, promote exit of M cells from the cell cycle and terminal differentiation of muscle cells.
